Cathie Wood’s ARK Invest Sells Over 350,000 Shares of Takeda Pharma
One of Cathie Wood's Ark Invest funds sold over 350,000 shares of Takeda Pharmaceutical on June 16.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 350,000 shares of Takeda Pharmaceutical Co. Ltd. (NYSE: TAK) on Wednesday, as the share price of this fund traded relatively flat in the day’s session. Its share price has greatly improved over the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 366,228 shares of Takeda. At Wednesday’s closing price, this would have valued this sale at roughly $6.2 million. This is only a small fraction of the total holdings. This fund is up 84% over the past 52 weeks.
Here is a quick look at all the other sales that took place across all ARK ETFs:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKF | TCSLI | TCS GROUP HOLDING PLC | 35,354 |
| ARKG | NVS | NOVARTIS AG | 128,903 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS INC | 1,357 |
| ARKG | SRPT | SAREPTA THERAPEUTICS INC | 22,178 |
| ARKG | TAK | TAKEDA PHARMACEUTICAL CO LTD | 366,228 |
| ARKQ | GLEO | GALILEO ACQUISITION CORP | 325,800 |
| ARKQ | NVDA | NVIDIA CORP | 4,050 |
| ARKQ | RAVN | RAVEN INDUSTRIES INC | 12,814 |
| ARKQ | TCEHY | TENCENT HOLDINGS LTD | 36,315 |
| ARKW | TCEHY | TENCENT HOLDINGS LTD | 46,793 |
| ARKW | PSTG | PURE STORAGE INC | 187,131 |
| ARKW | NET | CLOUDFLARE INC | 69,294 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=897200][wallst_email_signup]
Contact [email protected] for any questions or corrections.








